Literature DB >> 24126511

Management of ischemic diabetic foot.

C Caravaggi1, R Ferraresi, M Bassetti, A B Sganzaroli, P Galenda, S Fattori, R De Prisco, D Simonetti, F Bona.   

Abstract

Diabetic foot pathology represent the more disabling complication of diabetes. More the 1 million of diabetes patients undergo a lower limb amputation per year; 85% of these amputation are preceded by un ulcer that can be avoided by a prevention program. Critical limb ischemia (CLI), the only independent cause of major amputation in diabetic population, can be correctly treated when an early diagnosis is made. Both endoluminal and surgical revascularization procedures can be applied in diabetes with high rate of success when performed by skilled operator. Infection of diabetic foot, in particular in patients suffering from peripheral artery disease (PVD), may rapidly evolves in severe local or systemic infection putting the patient at high risk of major amputation or death. Together with an early diagnosis of infection and ischemia it is mandatory to apply a correct medical and surgical treatment protocol with the aim to control infection and to improve blood perfusion to the foot. In case of infection surgical procedure should be applied first while revascularization procedure will follow soonest. Antibiotic therapy should be chosen considering different local biological pattern and different type of infection. Reconstructive surgery, the last step in treatment of any diabetic foot lesion, must obtain a functional residual foot or a stump that will allow the patient to go back walking soonest with residual good walking capacity.

Entities:  

Mesh:

Year:  2013        PMID: 24126511

Source DB:  PubMed          Journal:  J Cardiovasc Surg (Torino)        ISSN: 0021-9509            Impact factor:   1.888


  8 in total

1.  Opportunities and challenges for repair of macrovascular disease using circulating blood-derived progenitor cells.

Authors:  Mary R Loeken
Journal:  Diabetes Metab Res Rev       Date:  2014-10       Impact factor: 4.876

2.  Study on the Effect of the Five-in-One Comprehensive Limb Salvage Technologies of Treating Severe Diabetic Foot.

Authors:  Yiling Liu; Yan Shi; Junyou Zhu; XiaoDong Chen; RongHua Yang; Bin Shu; Ziheng Zhou; Jian Liu; Ri-Qiang Wu; Julin Xie
Journal:  Adv Wound Care (New Rochelle)       Date:  2019-11-19       Impact factor: 4.730

Review 3.  The diabetic foot: the importance of coordinated care.

Authors:  Dean Y Huang; C Jason Wilkins; David R Evans; Thoraya Ammar; Colin Deane; Prashanth R Vas; Hisham Rashid; Paul S Sidhu; Michael E Edmonds
Journal:  Semin Intervent Radiol       Date:  2014-12       Impact factor: 1.513

4.  An explainable machine learning model for predicting in-hospital amputation rate of patients with diabetic foot ulcer.

Authors:  Puguang Xie; Yuyao Li; Bo Deng; Chenzhen Du; Shunli Rui; Wu Deng; Min Wang; Johnson Boey; David G Armstrong; Yu Ma; Wuquan Deng
Journal:  Int Wound J       Date:  2021-09-14       Impact factor: 3.099

5.  Diabetes impairs wound healing by Dnmt1-dependent dysregulation of hematopoietic stem cells differentiation towards macrophages.

Authors:  Jinglian Yan; Guodong Tie; Shouying Wang; Amanda Tutto; Natale DeMarco; Lyne Khair; Thomas G Fazzio; Louis M Messina
Journal:  Nat Commun       Date:  2018-01-02       Impact factor: 14.919

6.  Impact of time in range during hospitalization on clinical outcomes in diabetic patients with toe amputation: a propensity score matching analysis.

Authors:  Su Li; Ze-Xin Huang; Dong-Hao Lou; Ye-Yong Jiang; Sheng Zhao
Journal:  BMC Surg       Date:  2022-08-12       Impact factor: 2.030

Review 7.  Ozone therapy for treating foot ulcers in people with diabetes.

Authors:  Jian Liu; Peng Zhang; Jing Tian; Lun Li; Jun Li; Jin Hui Tian; KeHu Yang
Journal:  Cochrane Database Syst Rev       Date:  2015-10-27

8.  Static Magnetic Field Accelerates Diabetic Wound Healing by Facilitating Resolution of Inflammation.

Authors:  Wenlong Shang; Guilin Chen; Yinxiu Li; Yujuan Zhuo; Yuhong Wang; Zhicai Fang; Ying Yu; Huiwen Ren
Journal:  J Diabetes Res       Date:  2019-11-30       Impact factor: 4.011

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.